Skip to main content
. 2025 Jan 2;11(1):e189. doi: 10.1097/JW9.0000000000000189

Fig. 8.

Fig. 8.

Dermatologists’ attitudes regarding concern over AEs and use of TNFi prior to pregnancy, during pregnancy, and during breastfeeding in women with PSO. Dermatologists from Japan were asked to disregard patients with psoriatic arthritis when responding. These data do not add up to 100% due to a rounding error. AEs, adverse events; PSO, psoriasis; TNFi, tumor necrosis factor inhibitors.